{"id":741180,"date":"2023-03-20T08:24:01","date_gmt":"2023-03-20T12:24:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/"},"modified":"2023-03-20T08:24:01","modified_gmt":"2023-03-20T12:24:01","slug":"ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/","title":{"rendered":"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023"},"content":{"rendered":"
\n

SAN RAFAEL, Calif., March 20, 2023 (GLOBE NEWSWIRE) — Ekso Bionics (Nasdaq: EKSO) (the \u201cCompany\u201d), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2022 after the close of trading on Tuesday, March 28, 2023. Management will host a conference call beginning at 1:30 p.m. PT \/ 4:30 p.m. ET to discuss the financial results and recent business developments.<\/p>\n

A live webcast of the event will be available in the \u201cInvestors\u201d section of the Company\u2019s website at www.eksobionics.com<\/a>, or by clicking here<\/a>. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 for international callers.<\/p>\n

A webcast replay will also be available on the Company\u2019s website for one month following the completion of the call.<\/p>\n

\n About Ekso Bionics<\/strong>
\n \u00ae<\/sup>
\n \u00a0<\/strong>
\n
Ekso Bionics\u00ae is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only known exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. The Company is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol \u201cEKSO.\u201d For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.<\/p>\n

\n Investor Contact: <\/strong>
\n
David Carey
212-867-1768
investors@eksobionics.com<\/a><\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN RAFAEL, Calif., March 20, 2023 (GLOBE NEWSWIRE) — Ekso Bionics (Nasdaq: EKSO) (the \u201cCompany\u201d), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2022 after the close of trading on Tuesday, March 28, 2023. Management will host a conference call beginning at 1:30 p.m. PT \/ 4:30 p.m. ET to discuss the financial results and recent business developments. A live webcast of the event will be available in the \u201cInvestors\u201d section of the Company\u2019s website at www.eksobionics.com, or by clicking here. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 … <\/p>\n

Continue reading “Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-741180","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEkso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN RAFAEL, Calif., March 20, 2023 (GLOBE NEWSWIRE) — Ekso Bionics (Nasdaq: EKSO) (the \u201cCompany\u201d), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2022 after the close of trading on Tuesday, March 28, 2023. Management will host a conference call beginning at 1:30 p.m. PT \/ 4:30 p.m. ET to discuss the financial results and recent business developments. A live webcast of the event will be available in the \u201cInvestors\u201d section of the Company\u2019s website at www.eksobionics.com, or by clicking here. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 … Continue reading "Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-20T12:24:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023\",\"datePublished\":\"2023-03-20T12:24:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/\"},\"wordCount\":286,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/\",\"name\":\"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY=\",\"datePublished\":\"2023-03-20T12:24:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/","og_locale":"en_US","og_type":"article","og_title":"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023 - Market Newsdesk","og_description":"SAN RAFAEL, Calif., March 20, 2023 (GLOBE NEWSWIRE) — Ekso Bionics (Nasdaq: EKSO) (the \u201cCompany\u201d), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the fourth quarter and full year 2022 after the close of trading on Tuesday, March 28, 2023. Management will host a conference call beginning at 1:30 p.m. PT \/ 4:30 p.m. ET to discuss the financial results and recent business developments. A live webcast of the event will be available in the \u201cInvestors\u201d section of the Company\u2019s website at www.eksobionics.com, or by clicking here. Investors interested in listening to the conference call may do so by dialing 877-407-3036 for domestic callers or 201-378-4919 … Continue reading \"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-03-20T12:24:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023","datePublished":"2023-03-20T12:24:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/"},"wordCount":286,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/","name":"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY=","datePublished":"2023-03-20T12:24:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc5MTE1OCM1NDY5ODYwIzIwMjc5MzY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ekso-bionics-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-28-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Ekso Bionics to Report Fourth Quarter and Full Year 2022 Financial Results on March 28, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=741180"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/741180\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=741180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=741180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=741180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}